ArticleACS omega2023
Chitosan-Coated Niosomes Loaded with Ellagic Acid Present Antiaging Activity in a Skin Cell Line.
Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 37 citations in OpenAlex.
- Natural products targeting cytokine-regulated SASP inflammation networks in Ovarian cancer: Implications on immune escape and molecular resistance.Inflammopharmacology · 2026Review
- Formulation, characterization and evaluation of cytotoxic potential for febuxostat loaded chitosomes against cervical cancer cells (Hela cells).Scientific reports · 2026Article
- Catechin-Folate nano-niosomes from Osbeckia parvifolia Arn. induce apoptotic cell death in Ovarian cancer.Scientific reports · 2026Article
- Preparation and evaluation of citalopram novasomal vesicles as a transdermal analgesic drug delivery.Drug delivery and translational research · 2026Article
- Chitosan-Coated Niosomal Nanocarriers for the Co-Delivery of Glibenclamide and Curcumin in Diabetes Mellitus.Polymers · 2026Article
- "Acne vulgaris: key insights, treatment, and future prospects".Molecular diversity · 2026Review
- An Insight on Ellagic Acid Formulations for the Management of Skin Diseases.Molecules (Basel, Switzerland) · 2025Review
- Effect of Microparticle Crystallinity and Food Matrix on the Release Profile and Antioxidant Activity of Encapsulated Gallic and Ellagic Acids During Simulated In Vitro Intestinal Digestion.Antioxidants (Basel, Switzerland) · 2025Article
- Chitosan Nanoparticles Loaded with Polyphenols for Cosmeceutical Applications: A State-of-the-Art Review.Pharmaceutics · 2025Review
- Attenuating Effect of a Polyphenol Ellagic Acid on Ovarian Aging by Inhibiting the Ferroptosis Pathway in Low-Yield Laying Chickens.Antioxidants (Basel, Switzerland) · 2025Article
- Cardioprotective Potential ofCurrent pharmaceutical biotechnology · 2025Article
- Pomegranate (Molecules (Basel, Switzerland) · 2024Review
- Natural Modulators of Key Signaling Pathways in Skin Inflammageing.Clinical, cosmetic and investigational dermatology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The polyphenol compound ellagic acid (EA) extracted from pomegranate has potential bioactivity against different types of chronic diseases. Skin aging is a long-term physiological process caused by many environmental factors, the most important of which is exposure to sun ultraviolet (UV) radiation. UV-induced chronic photodamage of the skin results in extrinsic aging. This study aimed to evaluate the photoprotective effects of EA on the human fibroblast skin cell line HFB4 and investigate its capacity to protect collagen from UV-induced deterioration. EA was encapsulated into chitosan-coated niosomes to reduce the skin aging effect of UV radiation in vitro. The tested formulations (niosomes loaded with EA and chitosan-coated niosomes loaded with EA) were characterized using transmission electron microscopy, dynamic light scattering, and scanning electron microscopy. Furthermore, the in vitro release of EA was determined. The HFB4 cell line samples were split into five groups: control, UV, UV-EA, UV-NIO-EA, and UV-CS-NIO-EA. UV irradiation was applied to the cell line groups via a UV-emitting lamp for 1 h, and then cell viability was measured for each group. The expression of genes implicated in skin aging (Co1A1, TERT, Timp3, and MMP3) was also assessed to quantify the impact of the loaded EA. The findings showed that EA-loaded chitosan-coated niosomes improved cell survival, upregulated Col1A1, TERT, and Timp3 genes, and downregulated MMP3. Thus, nanoparticles encapsulating EA are potent antioxidants that can preserve collagen levels and slow down the aging process in human skin.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.